The basis of the NOA device is its ability to measure the fraction of Exhaled Nitric Oxide (FeNO) of human breath, which is a marker already standardised by leading bodies such as the European Respiratory Society, and by The National Institute for Health and Care Excellence -NICE-.

NOA device objectively monitors asthma in a simple, painless, non-invasive and precise way, with accurate and immediate results. The NOA is useful for both preventive and post-treatment monitoring.

Product conception by Vidorreta Design